SCOPE: Hydroxytyrosol (HT), a polyphenol from olives, is a potential anticancer agent. This study was designed to evaluate the anticancer activity of HT against prostate cancer cells, and the mechanism thereof. METHODS AND RESULTS: Treatment of LNCaP and C4-2 prostate cancer cells with HT resulted in a dose-dependent inhibition of proliferation. This was in contrast to HT's ineffectiveness against normal prostate epithelial cells RWPE1 and PWLE2, suggesting cancer-cell-specific effect. HT induced G1/S cell cycle arrest, with inhibition of cyclins D1/E and cdk2/4 and induction of inhibitory p21/p27. HT also induced apoptosis, as confirmed by flow cytometry, caspase activation, PARP cleavage, and BAX/Bcl-2 ratio. It inhibited the phosphorylation of Akt/STAT3, and induced cytoplasmic retention of NF-κB, which may explain its observed effects. Finally, HT inhibited androgen receptor (AR) expression and the secretion of AR-responsive prostate-specific antigen. CONCLUSION: Castration-resistant prostate cancers retain AR signaling and are often marked by activated Akt, NF-κB, and STAT3 signaling. Our results establish a pleiotropic activity of HT against these oncogenic signaling pathways. Combined with its nontoxic effects against normal cells, our results support further testing of HT for prostate cancer therapy.
SCOPE: Hydroxytyrosol (HT), a polyphenol from olives, is a potential anticancer agent. This study was designed to evaluate the anticancer activity of HT against prostate cancer cells, and the mechanism thereof. METHODS AND RESULTS: Treatment of LNCaP and C4-2 prostate cancer cells with HT resulted in a dose-dependent inhibition of proliferation. This was in contrast to HT's ineffectiveness against normal prostate epithelial cells RWPE1 and PWLE2, suggesting cancer-cell-specific effect. HT induced G1/S cell cycle arrest, with inhibition of cyclins D1/E and cdk2/4 and induction of inhibitory p21/p27. HT also induced apoptosis, as confirmed by flow cytometry, caspase activation, PARP cleavage, and BAX/Bcl-2 ratio. It inhibited the phosphorylation of Akt/STAT3, and induced cytoplasmic retention of NF-κB, which may explain its observed effects. Finally, HT inhibited androgen receptor (AR) expression and the secretion of AR-responsive prostate-specific antigen. CONCLUSION: Castration-resistant prostate cancers retain AR signaling and are often marked by activated Akt, NF-κB, and STAT3 signaling. Our results establish a pleiotropic activity of HT against these oncogenic signaling pathways. Combined with its nontoxic effects against normal cells, our results support further testing of HT for prostate cancer therapy.
Authors: G Toteda; S Lupinacci; D Vizza; R Bonofiglio; E Perri; M Bonofiglio; D Lofaro; A La Russa; F Leone; P Gigliotti; R A Cifarelli; A Perri Journal: J Endocrinol Invest Date: 2016-09-03 Impact factor: 4.256
Authors: Andrea Di Francesco; Anastasia Falconi; Clara Di Germanio; Maria Vittoria Micioni Di Bonaventura; Antonio Costa; Stefano Caramuta; Michele Del Carlo; Dario Compagnone; Enrico Dainese; Carlo Cifani; Mauro Maccarrone; Claudio D'Addario Journal: J Nutr Biochem Date: 2014-12-03 Impact factor: 6.048
Authors: Alberto M Parra-Perez; Amalia Pérez-Jiménez; Isabel Gris-Cárdenas; Gloria C Bonel-Pérez; Luis M Carrasco-Díaz; Khalida Mokhtari; Leticia García-Salguero; José A Lupiáñez; Eva E Rufino-Palomares Journal: Int J Mol Sci Date: 2022-06-24 Impact factor: 6.208
Authors: Chloe D Goldsmith; Danielle R Bond; Helen Jankowski; Judith Weidenhofer; Costas E Stathopoulos; Paul D Roach; Christopher J Scarlett Journal: Int J Mol Sci Date: 2018-07-02 Impact factor: 5.923
Authors: Jesús Calahorra; Esther Martínez-Lara; José M Granadino-Roldán; Juan M Martí; Ana Cañuelo; Santos Blanco; F Javier Oliver; Eva Siles Journal: Sci Rep Date: 2020-04-14 Impact factor: 4.379